loading

Moonlake Immunotherapeutics Azioni (MLTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
31.88%
19.82
15.03 12.98 13.19 12.93
Operating Income/Loss
31.88%
-19.82
-15.03 -12.98 -13.19 -12.93
Income/Loss From Continuing Operations Before Tax
77.29%
-13.91
-7.8431 -11.59 -12.35 -12.22
Income Tax Expense/Benefit
58.55%
0.0703
0.0443 0.0289 0.0101 0.011
Income/Loss From Continuing Operations After Tax
77.19%
-13.98
-7.8874 -11.62 -12.35 -12.22
Net Income/Loss
77.19%
-13.98
-7.8874 -11.62 -12.35 -12.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
32.97%
-0.3019
-0.4503 -2.1933 -2.2141 -3.2141
Basic Average Shares
1,622%
62.64
3.6369 53.52 43.72 39.06
Diluted Average Shares
1,622%
62.64
3.6369 53.52 43.72 39.06
Basic Earnings Per Share
120.00%
-0.22
-0.10 -0.18 -0.23 -0.23
Diluted Earnings Per Share
120.00%
-0.22
-0.10 -0.18 -0.23 -0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):